Peter Barland

2.2k total citations · 1 hit paper
60 papers, 1.7k citations indexed

About

Peter Barland is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Peter Barland has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 17 papers in Immunology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Peter Barland's work include Systemic Lupus Erythematosus Research (23 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Renal Diseases and Glomerulopathies (8 papers). Peter Barland is often cited by papers focused on Systemic Lupus Erythematosus Research (23 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Renal Diseases and Glomerulopathies (8 papers). Peter Barland collaborates with scholars based in United States, United Kingdom and Norway. Peter Barland's co-authors include David Hamerman, Alex B. Novikoff, Arthur I. Grayzel, Alan L. Epstein, Mark Jarrett, Leonarda B. Sablay, Norman Bank, John Sandson, Max Hamburger and Rosamond Janis and has published in prestigious journals such as Nature, New England Journal of Medicine and The Journal of Cell Biology.

In The Last Decade

Peter Barland

58 papers receiving 1.5k citations

Hit Papers

ELECTRON MICROSCOPY OF THE HUMAN SYNOVIAL MEMBRANE 1962 2026 1983 2004 1962 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Barland United States 23 808 335 237 231 215 60 1.7k
E Hedfors Sweden 23 698 0.9× 478 1.4× 186 0.8× 227 1.0× 248 1.2× 48 1.8k
P. Oxholm Denmark 24 306 0.4× 415 1.2× 161 0.7× 379 1.6× 99 0.5× 81 1.8k
Otto Wegelius Finland 25 374 0.5× 247 0.7× 502 2.1× 240 1.0× 160 0.7× 107 1.6k
Koichi Fujii Japan 23 466 0.6× 334 1.0× 371 1.6× 174 0.8× 104 0.5× 57 1.6k
Pierre‐André Guerne Switzerland 25 1.0k 1.3× 442 1.3× 407 1.7× 251 1.1× 112 0.5× 40 1.9k
C. William Castor United States 28 573 0.7× 380 1.1× 573 2.4× 268 1.2× 140 0.7× 80 2.3k
A. Facchini Italy 31 574 0.7× 787 2.3× 481 2.0× 394 1.7× 101 0.5× 127 2.6k
Hiroaki Ueki Japan 24 431 0.5× 471 1.4× 368 1.6× 115 0.5× 96 0.4× 124 1.8k
M F Kahn France 19 432 0.5× 236 0.7× 199 0.8× 297 1.3× 215 1.0× 51 1.2k
Hobart W. Walling United States 23 632 0.8× 179 0.5× 389 1.6× 212 0.9× 67 0.3× 70 2.2k

Countries citing papers authored by Peter Barland

Since Specialization
Citations

This map shows the geographic impact of Peter Barland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Barland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Barland more than expected).

Fields of papers citing papers by Peter Barland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Barland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Barland. The network helps show where Peter Barland may publish in the future.

Co-authorship network of co-authors of Peter Barland

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Barland. A scholar is included among the top collaborators of Peter Barland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Barland. Peter Barland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abadi, Maria, et al.. (2011). A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clinical Rheumatology. 30(10). 1385–1392. 58 indexed citations
2.
Barland, Peter, et al.. (2006). Trigeminal Neuralgia as the First Manifestation of Mixed Connective Tissue Disorder. JCR Journal of Clinical Rheumatology. 12(3). 145–147. 20 indexed citations
3.
Zandman‐Goddard, Gisele, Elena Peeva, & Peter Barland. (2002). Combined Autoimmune Disease in a Patient with AIDS. Clinical Rheumatology. 21(1). 70–72. 9 indexed citations
4.
Sinha, Jayashree, et al.. (2002). Brachial plexopathy as a presenting symptom of giant cell arteritis.. PubMed. 29(12). 2653–7. 9 indexed citations
5.
Lichauco, Juan Javier, Simeon A. Lauer, Hidenobu Shigemitsu, et al.. (2001). Orbital mucosa-associated lymphoid tissue (MALT)-type lymphoma in a patient with relapsing polychondritis. Arthritis & Rheumatism. 44(7). 1713–1715. 19 indexed citations
6.
Peeva, Elena, et al.. (2000). Rheumatoid arthritis exacerbation caused by exogenous interleukin-12. Arthritis & Rheumatism. 43(2). 461–461. 18 indexed citations
7.
Barland, Peter. (1997). Introduction: Rheumatology today: Pathways to progress. The American Journal of Medicine. 102(1). 1S–2S. 2 indexed citations
8.
Aranow, Cynthia, et al.. (1996). Reactivation of Inactive Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology. 25(5). 282–286. 2 indexed citations
9.
Barland, Peter, et al.. (1996). Selection and use of laboratory tests in the rheumatic diseases. The American Journal of Medicine. 100(2). 16S–23S. 35 indexed citations
10.
Glicklich, Daniel, et al.. (1989). Effect of long-term normalization of serum complement levels on the course of lupus nephritis. The American Journal of Medicine. 87. 132–138. 1 indexed citations
11.
Sablay, Leonarda B., et al.. (1989). Effect of long-term normalization of serum complement levels on the course of lupus nephritis. The American Journal of Medicine. 87(2). 132–138. 25 indexed citations
12.
Epstein, Alan L., et al.. (1986). The clinical application of an ELISA technique for the detection of antihistone antibodies.. PubMed. 13(2). 304–7. 17 indexed citations
13.
Barland, Peter, et al.. (1981). Cytotoxic factors specific for endothelial cells. Progressive systemic sclerosis without cutaneous involvement.. PubMed. 81(7). 1081–3. 2 indexed citations
14.
Reinitz, Elizabeth, Arthur I. Grayzel, & Peter Barland. (1980). Specification of sm antibody. Arthritis & Rheumatism. 23(7). 869–869. 5 indexed citations
15.
Jarrett, Mark, Gerald Schiffman, Peter Barland, & Arthur I. Grayzel. (1980). Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis & Rheumatism. 23(11). 1287–1293. 57 indexed citations
16.
Reinitz, Elizabeth & Peter Barland. (1980). Whole blood exchange for systemic lupus erythematosus. Arthritis & Rheumatism. 23(7). 868–869.
17.
Sablay, Leonarda B., et al.. (1978). The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis. The American Journal of Medicine. 64(2). 274–283. 59 indexed citations
18.
Lentz, Kenneth E., John B. Winfield, & Peter Barland. (1976). Antibodies to dAT detected by membrane filtration. Arthritis & Rheumatism. 19(5). 867–873. 7 indexed citations
19.
Hamerman, David & Peter Barland. (1966). Structure and function of the synovial membrane.. PubMed. 16(5). 396–9. 23 indexed citations
20.
Barland, Peter, Rosamond Janis, & John Sandson. (1966). Immunofluorescent Studies of Human Articular Cartilage. Annals of the Rheumatic Diseases. 25(2). 156–164. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026